IBB
IBB
iShares Biotechnology ETF • IShares
$171.40 ▼ -0.57% (-0.99)
Managing Company IShares
Asset Under Management $8.62B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $107.43
Volume 1,743,258
Avg Volume 2,065,658
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Managing Company IShares
Asset Under Management $8.62B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $107.43
Volume 1,743,258
Avg Volume 2,065,658
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 VRTX | Vertex Pharmaceuticals Incorporated | 8.81% | 1.61M | $779.37M |
 GILD | Gilead Sciences, Inc. | 7.80% | 5.55M | $689.75M |
 AMGN | Amgen Inc. | 7.80% | 2.02M | $690.29M |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.93% | 754.42K | $612.80M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 4.62% | 967.43K | $408.74M |
 INSM | Insmed Incorporated | 3.12% | 1.57M | $275.96M |
 NTRA | Natera, Inc. | 2.82% | 979.20K | $249.11M |
 ARGX | argenx SE | 2.81% | 301.75K | $248.32M |
 BIIB | Biogen Inc. | 2.31% | 1.09M | $204.08M |
 ONC | BeOne Medicines Ltd. | 2.03% | 539.08K | $179.98M |
 ILMN | Illumina, Inc. | 1.88% | 1.11M | $166.24M |
 INCY | Incyte Corporation | 1.81% | 1.45M | $160.08M |
 UTHR | United Therapeutics Corporation | 1.76% | 309.67K | $155.98M |
 RVMD | Revolution Medicines, Inc. | 1.43% | 1.23M | $126.58M |
 GMAB | Genmab A/S | 1.40% | 3.67M | $124.27M |
 MEDP | Medpace Holdings, Inc. | 1.17% | 168.47K | $103.29M |
 NBIX | Neurocrine Biosciences, Inc. | 1.15% | 723.76K | $101.77M |
 IONS | Ionis Pharmaceuticals, Inc. | 1.11% | 1.18M | $98.50M |
 MRNA | Moderna, Inc. | 1.05% | 2.58M | $92.74M |
 BBIO | BridgeBio Pharma, Inc. | 1.03% | 1.23M | $91.11M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Denmark
Cayman Islands
United Kingdom
Canada
Germany
France
Ireland
Switzerland
Singapore Other
0.17%
Australia
China
Jersey
Belgium
Spain
Italy
Iceland.svg)
Taiwan (Province of China)SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Denmark Cayman Islands United Kingdom Canada Germany France Ireland Switzerland Singapore Other
0.17% Australia China Jersey Belgium Spain Italy Iceland Taiwan (Province of China)Holdings (Top 20)
VRTX
Vertex Pharmaceuticals Incorporated
Weight: 8.81% Shares: 1.61M Value: $779.37M
GILD
Gilead Sciences, Inc.
Weight: 7.80% Shares: 5.55M Value: $689.75M
AMGN
Amgen Inc.
Weight: 7.80% Shares: 2.02M Value: $690.29M
REGN
Regeneron Pharmaceuticals, Inc.
Weight: 6.93% Shares: 754.42K Value: $612.80M
ALNY
Alnylam Pharmaceuticals, Inc.
Weight: 4.62% Shares: 967.43K Value: $408.74M
INSM
Insmed Incorporated
Weight: 3.12% Shares: 1.57M Value: $275.96M
NTRA
Natera, Inc.
Weight: 2.82% Shares: 979.20K Value: $249.11M
ARGX
argenx SE
Weight: 2.81% Shares: 301.75K Value: $248.32M
BIIB
Biogen Inc.
Weight: 2.31% Shares: 1.09M Value: $204.08M
ONC
BeOne Medicines Ltd.
Weight: 2.03% Shares: 539.08K Value: $179.98M
ILMN
Illumina, Inc.
Weight: 1.88% Shares: 1.11M Value: $166.24M
INCY
Incyte Corporation
Weight: 1.81% Shares: 1.45M Value: $160.08M
UTHR
United Therapeutics Corporation
Weight: 1.76% Shares: 309.67K Value: $155.98M
RVMD
Revolution Medicines, Inc.
Weight: 1.43% Shares: 1.23M Value: $126.58M
GMAB
Genmab A/S
Weight: 1.40% Shares: 3.67M Value: $124.27M
MEDP
Medpace Holdings, Inc.
Weight: 1.17% Shares: 168.47K Value: $103.29M
NBIX
Neurocrine Biosciences, Inc.
Weight: 1.15% Shares: 723.76K Value: $101.77M
IONS
Ionis Pharmaceuticals, Inc.
Weight: 1.11% Shares: 1.18M Value: $98.50M
MRNA
Moderna, Inc.
Weight: 1.05% Shares: 2.58M Value: $92.74M
BBIO
BridgeBio Pharma, Inc.
Weight: 1.03% Shares: 1.23M Value: $91.11M